ACHE and diabetic cardiomyopathy: The results showed that pyridostigmine decreased AChE activity, increased ACh levels in serum and in gut and cardiac tissues, and exerted beneficial effects on insulin resistance and cardiac damage in diabetic cardiomyopathy mice.